chr1-179575741-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014625.4(NPHS2):c.124G>A(p.Gly42Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000596 in 1,516,052 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G42A) has been classified as Uncertain significance.
Frequency
Consequence
NM_014625.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00343 AC: 521AN: 152050Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.000794 AC: 90AN: 113346Hom.: 1 AF XY: 0.000633 AC XY: 40AN XY: 63148
GnomAD4 exome AF: 0.000280 AC: 382AN: 1363896Hom.: 2 Cov.: 31 AF XY: 0.000254 AC XY: 171AN XY: 673002
GnomAD4 genome AF: 0.00342 AC: 521AN: 152156Hom.: 4 Cov.: 32 AF XY: 0.00296 AC XY: 220AN XY: 74386
ClinVar
Submissions by phenotype
Nephrotic syndrome, type 2 Benign:2
- -
- -
Steroid-resistant nephrotic syndrome Uncertain:1
- -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at